- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- AstraZeneca (NYSE: AZN) hit a new 52-week high Monday as it is currently trading at $50.16, above its previous 52-week high of $50.14 with 258,118 shares traded as of 10:10 a.m. ET. Average volume has been two million shares over the past 30 days. AstraZeneca has a market cap of $62.31 billion and is part of the health care sector and drugs industry. Shares are up 5.7% year to date as of the close of trading on Thursday. AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammation diseases worldwide. The company has a P/E ratio of 10, below the S&P 500 P/E ratio of 17.7.